 
                  
Serum Institute of India: 1 crore doses of Quadrivalent Human Papillomavirus vaccine by December 2022
Serum Institute tells Centre it can supply 1 crore doses of its indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, by December 2022
 
